$GOVX: NEWS--- Leveraging GeoVax's Vaccine Expertise To

New Post Public Reply Private Reply Replies (0) Message Board
SHEEPWOLF
408
$GOVX: NEWS---

Leveraging GeoVax's Vaccine Expertise To Take On Cancer
ATLANTA, GA, September 9, 2019 – GeoVax Labs, Inc. (OTCQB:GOVX), a biotechnology company developing human immunotherapies and vaccines has historically been associated with the development of vaccines against infectious diseases. The company is now leveraging the knowledge and expertise it has validated in infectious diseases and expanding the applicability of MVA-VLP into immuno-oncology (IO) with highly promising results.

The company's Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform technology has been successfully validated in multiple development programs, including HIV, Zika, and Hemorrhagic Fevers such as Ebola, Marburg and Lassa. However, the advancement of these critical programs into clinical development has been challenging. GeoVax is now leveraging the knowledge and expertise it has validated in infectious diseases and expanding the applicability of MVA-VLP into immuno-oncology (IO) with highly promising results.

The safety and efficacy of the MVA platform are well recognized and accepted. Originally developed as a safer vaccine against smallpox in the 1950s, MVA now serves as validated vector delivery foundation technology on which the development of new vaccine candidates are built. MVA vaccines have been tested on over 120,000 people, demonstrating outstanding safety, especially in immunocompromised individuals. Importantly, MVA vaccines have been found immunogenic and protective in various preclinical models and human clinical trials, including in HIV, HBV, MERS, avian influenza virus H5N1, Ebola, Zika, and Mycobacterium tuberculosis (Volz & Sutter, Adv. Virus Res, 2017).

Scientists at GeoVax have been able to capitalize and build on the MVA platform by utilizing recombinant DNA technology to incorporate Virus-Like Particles (VLPs) into the MVA delivery construct. VLPs are non-infectious portions of the pathogenic virus or bacteria. Often they are truncated forms of a surface protein or receptor. They are big enough to elicit an immune response and confer immunity, but have no risk of causing infection or harm; this is in contrast to weakened (attenuated) or killed forms of the virus, like the current influenza virus vaccines. GeoVax has conducted six human trials of the MVA-VLP platform in more than 500 subjects with no serious adverse reactions. The GeoVax MVA-VLP platform and approach has been well documented and validated in the multitude of trials........

https://geovax.reportablenews.com/pr/leveragi...-on-cancer
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AptarGroup Faces Investigation: Shareholder Stakes High

Updated Category News Views 89

AptarGroup Directors Under Investigation Every seasoned investor knows the market isn’t just sunshine and rainbows. Lately, the storm clouds have gathered over AptarGroup, Inc. (NYSE: ATR). Out of nowhere comes Purcell & Lefkowitz LLP, announcing a shareholder investigation that sends shivers down the spines of those who've put their money on this packaging...

Continue Reading
Villas of Distinction Shines: Bags 11th Gold Travvy

Updated Category News Views 125

Claiming Top Spot Repeatedly Another year, another accolade—Villas of Distinction has clutched its 11th Gold Travvy Award for "Best Villa Rental Company – Overall." This accolade ain't no small potatoes, as it's a testament to the company's unwavering excellence recognized by travel advisors worldwide. These folks, who have their fingers on the pulse of the industry,...

Continue Reading
MoreBetter's Therapy Co-Investment: A Big Bet on Patient Data

Updated Category News Views 0

Diving Into Uncharted Waters with Bold Moves MoreBetter is stepping right into the murky, unpredictable world of longevity, peptide, and psychedelic therapies with a fresh initiative—the RWE Co-Investment Program. This isn't your run-of-the-mill study announcement; it's a gutsy leap into largely unexplored areas of patient-reported outcomes and real-world evidence. A...

Continue Reading
ANTHBOT Rolls Out Black Friday Deals on Mowers

Updated Category News Views 79

ANTHBOT's Bold Black Friday Play Alright, here's something that'll perk up any garden-variety technophile: ANTHBOT's slashing prices on its M5 and M9 robotic lawn mowers as part of their "Easy Mowing. Extra Savings." campaign. Now, I've been around the block enough to know that discounts get flung around like confetti this time of year, but a $250 slash on these...

Continue Reading
Jinko Solar Joins B20 Summit: Energy Forefront Focus

Updated Category News Views 80

Jinko Solar's Invitation to the B20 Summit Never a dull moment in the solar space, especially when Jinko Solar, a big shot in clean energy, jumps into the spotlight at the B20 Summit in the U.S. Awash with high-profile discussions, Jinko's not just chatting—it's the only photovoltaic firm strutting its stuff in D.C. with gutsy calls for energy reform. Key Takeaways from...

Continue Reading
Lauri Thompson Joins UWSN Board: A New Era Begins

Updated Category News Views 108

Fresh Faces and New Perspectives In a move that merges legal acumen with community heart, Lauri S. Thompson of Greenberg Traurig has stepped up as a board member for the United Way of Southern Nevada (UWSN). Now, why should we care about this? Because when someone with Thompson's clout and eight-arm octopus of involvement links up with a nonprofit, things get interesting....

Continue Reading
Mather Promotes Connection with Free Gardening Kits

Updated Category News Views 37

Winter Loneliness No Match for Mather’s Green Thumb Initiative Here's something heartfelt coming out of the Windy City: gardening kits. This ain't your standard Wall Street babble—it's about a nonprofit called Mather trying to shed some light on the colder months by giving seniors in Illinois a damn good reason to be joyfully busy. No boilersuit and tie needed, just a...

Continue Reading
Parachute Health Urges HME Transformation Through Collaboration

Updated Category News Views 130

The Road to Digital Unity in HME Cranking through the gears of the healthcare industry is no mean feat, but Parachute Health seems ready to throw some fresh oil on the machine. In a landscape riddled with complexities, they're sounding the call for a more unified digital infrastructure in the Home Medical Equipment (HME) sector through their latest white paper. We're...

Continue Reading
Wood Partners Commences on 301-Unit Alta Meadowlands

Updated Category News Views 52

Planting the Seeds for Alta Meadowlands It's all systems go for Wood Partners and GrayCo as they kick off construction on Alta Meadowlands in Hillsborough, North Carolina. Now, this isn't just another boxy warehouse masquerading as an apartment complex. We're talking a real commitment to shaking up the local real estate scene—a 301-unit community right in the...

Continue Reading
YouFit's $10M Club Overhaul: Skyline's Fitness Bet

Updated Category News Views 54

Fresh Faces and New Beginnings: YouFit's Big Bet They say if you're not evolving, you're dying. In the fitness world, staying static is asking to be left in the dust. YouFit Gyms just scored a $10 million-plus windfall from Skyline Investors, a California-based private equity outfit with an eye on transforming tired corners into fresh fitness hubs. This move signals big...

Continue Reading
e News Articles" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles